2002 Experimental Biology Meeting
Interim Meeting of the AACBNC
Experimental Biology '2002
An executive committee meeting and an interim
meeting and socializer are planned  for  the AACBNC
at EB ’2002 in New Orleans on Saturday, April 20. The
executive committee meeting will be held from 4:00 - 5:
30 pm, and the interim meeting/socializer will be held
from 5:30-7:30 pm.  These functions will be held at the
Hilton New Orleans Riverside which is 1.2 miles from
the Convention Center.  The room for the Executive
Committee Meeting is the Ascot.  The socializer will be
held in the Elmwood.  Both rooms are on the third
floor.  The dates of EB '2002 are Saturday, April 20 -
Wednesday, April 24, 2002.

The socializer will be sponsored by The Anatomical
Record, a Wiley-Liss publication.  Members are
encouraged to bring their spouse or a guest.
Experimental Biology '2002 should be
well attended.  Member societies
represented will be:

The American Association of Anatomists

The American Physiological Society

American Society for Pharmacology and                          
Experimental Therapeutics

American Society for Investigative Pathology

American Society for Nutritional Sciences

American Society for Biochemistry and Molecular          

The American Association of Immunologists
Guest Societies of the American
Association of Anatomists will be:

American Association of Veterinary Anatomists

Cajal Club
Information for the submission of abstracts
to Experimental Biology '2002 can be found
Keynote Address   
for the American Association of  Anatomists
at EB '2002

Supported by JEOL USA, Inc.

Organized by Stephen W. Carmichael, Ph.D.
President-Elect of the AACBNC

"Nitric Oxide and Cytokines Mediate Responses to
Stress and Inflammation"


Samuel M. McCann, M.D.
Pennington Biomedical Research Center
Louisiana State University
Chairpersons' Symposium

for the American Association of Anatomists at EB '2002
Organized by  David B. Burr, Ph.D.
President of the AACBNC
The utility of stem cell biology in future therapeutic
treatments is widely recognized. In the future, stem
cells will be modified and reprogrammed to treat a
diverse set of diseases and injuries including
Parkinson's disease, spinal cord injuries, diabetes,
cardiovascular disease and muscleloskeletal
conditions, among others. The use of stem cells in
research has generated both scientific and political
debate over the past several years. The interest in
and importance of this highly charged field for the
future of medical treatment dictates the need to
review some of the most recent and most important
advances in this dynamic area.

Four talks highlighting different aspects of stem cell
biology will be given. Dr. Darwin Prockop will provide
an overview of stem cell biology and will discuss the
role that stem cells can play in treatment of various
musculokeletal diseases. Dr. Mark Pittenger will
discuss mechanisms of signal transduction in
mesenchymal stem cells. Dr. Paul Carvey will talk about
his work to push progenitor cells to dopamine cells for
the treatment of Parkinson's disease and other
conditions. Dr. Evan Snyder will discuss the use of ES
cells as a source for neural stem cells and their use in
therapies for certain neurodegenerative diseases.

This Symposium will encompass the newest and most
exciting aspects in the field of stem cell biology.  All
the speakers are well known and highly respected for
their work.

Paul M. Carvey, Ph.D. - Rush-Presbyterian-St. Luke's
Driving Mesencephalic Stem Cells to Dopamine Neurons

Mark Pittenger, Ph.D.  - Osiris Therapeutics Inc.
Characteristics of Adult MSCs and Their Therapeutic

Darwin J. Prockop, M.D., Ph.D. - Center for Gene
Properties and Potential Use of Marrow Stromal Cells

Evan Snyder, M.D., Ph.D. - Harvard Medical School
Neural Stem Cells: Developmental Insights May Suggest
Novel Therapies for the Nervous System